Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Team members at the Weill Cornell Medicine Epilepsy Center conduct and participate in basic science and clinical research to evaluate new therapies for epilepsy.
Our team is proud to have played a significant role in developing and assessing most of the new anti-seizure medications available today. We continue to conduct clinical trials to develop new, better drugs.
Specialists at Weill Cornell Medicine Epilepsy Center have been crucial in developing:
Patients whose epilepsy is not responding to standard treatments may participate in a clinical trial testing a new approach. Participation in a clinical trial is voluntary.
Patients enrolled in an investigational study at Weill Cornell Medicine Epilepsy Center receive: